Education
About Us
Working with TipRanks
Follow Us
Doximity (DOCS)
NYSE:DOCS
DOCS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$40.87 - $85.21
Previous CloseN/A
Volume296.07K
Average Volume (3M)1.30M
Market Cap
$13.77B
Enterprise Value$11.51B
Total Cash (Recent Filing)$840.97M
Total Debt (Recent Filing)$11.84M
Price to Earnings (P/E)62.3
Beta1.29
Next Earnings
Nov 06, 2025EPS Estimate
0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.36
Shares Outstanding136,400,250
10 Day Avg. Volume1,226,107
30 Day Avg. Volume1,298,070
Financial Highlights & Ratios
PEG Ratio0.92
Price to Book (P/B)10.01
Price to Sales (P/S)19.01
P/FCF Ratio40.65
Enterprise Value/Market Cap0.84
Enterprise Value/Revenue19.52
Enterprise Value/Gross Profit21.65
Enterprise Value/Ebitda44.42
Forecast
1Y Price Target
$71.06Price Target Upside8.31% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering18
Bulls Say, Bears Say
Bulls Say
Financial PerformanceDoximity boasts strong financial metrics, including a 118% Net Revenue Retention (NRR), and impressive adjusted EBITDA margin and free cash flow generation.
Product InnovationThe announced acquisition of Pathway AI, an AI clinical reference company, should enhance DOCS' strategy and further build the competitive moat.
Strategic PartnershipsDoximity is a strategic partner for pharma and provider clients, with over 80% of US physicians, 60% of nurse practitioners, and 90% of medical students on its platform.
Bears Say
Advertising TrendsDOCS growth visibility is limited by uncertain pharma digital advertising trends and macro uncertainty.
Competitive PressurePossible risks to digital pharma ad budgets, high level of competition and DOCS’ current valuation warrant rating D/G to UW relative to coverage.
Valuation ConcernsDespite a strong financial profile, the current valuation premium of Doximity is viewed as excessive, warranting a relative Underweight rating.
Doximity News
DOCS FAQ
What was Doximity’s price range in the past 12 months?
Doximity lowest stock price was $40.87 and its highest was $85.21 in the past 12 months.
What is Doximity’s market cap?
Doximity’s market cap is $13.77B.
When is Doximity’s upcoming earnings report date?
Doximity’s upcoming earnings report date is Nov 06, 2025 which is in 26 days.
How were Doximity’s earnings last quarter?
Doximity released its earnings results on Aug 07, 2025. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.302 by $0.058.
Is Doximity overvalued?
According to Wall Street analysts Doximity’s price is currently Undervalued.
Does Doximity pay dividends?
Doximity does not currently pay dividends.
What is Doximity’s EPS estimate?
Doximity’s EPS estimate is 0.38.
How many shares outstanding does Doximity have?
Doximity has 136,400,250 shares outstanding.
What happened to Doximity’s price movement after its last earnings report?
Doximity reported an EPS of $0.36 in its last earnings report, beating expectations of $0.302. Following the earnings report the stock price went up 13.715%.
Which hedge fund is a major shareholder of Doximity?
Currently, no hedge funds are holding shares in DOCS
Doximity Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$71.06 (8.31% Upside)
$71.06 (8.31% Upside)
Blogger Sentiment
Bullish
DOCS Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 148.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 12.7%
Last 30 Days ▲ 12.7%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
51.34%
12-Months-Change
Fundamentals
Return on Equity
24.25%
Trailing 12-Months
Asset Growth
12.20%
Trailing 12-Months
Company Description
Doximity
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
DOCS Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a largely positive outlook with strong financial performance, significant user growth, and successful product launches. However, there are concerns regarding policy uncertainties and the lack of immediate revenue contribution from recent acquisitions.View all DOCS earnings summariesDOCS Revenue Breakdown
93.00% Subscription
7.00% Other
DOCS Stock 12 Month Forecast
Average Price Target
$71.06
▲(8.31% Upside)
Technical Analysis
Omnicell
―
Evolent Health
―
Teladoc
―
Definitive Healthcare Corp
―
Tempus AI, Inc. Class A
―
Ownership Overview
2.42% Insiders
31.75% Mutual Funds
26.99% Other Institutional Investors
19.55% Public Companies and Individual Investors